Skip to main content

Methotrexate: CBC within 12 weeks

CBE ID
0598
1.4 Project
Musculoskeletal Endorsement Maintenance
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Spring 2014
Is Under Review
No
1.3 Measure Description

This measure identifies adult patients with rheumatoid arthritis who were prescribed at least a 6-month supply of methotrexate during the measurement year and received a CBC test within 120 days (3 months + 1 month grace period) following the earliest observed methotrexate prescription claim

    • 1.14 Numerator

      Patients in the denominator who received a CBC test within 120 days following the earliest observed methotrexate prescription claim

      Time Window: See below

    • 1.15 Denominator

      Patients >=18 years old with rheumatoid arthritis who have received at least a 6-month supply of oral methotrexate during the measurement year

      Time Window: See below

    • Exclusions

      Exclude members with an inpatient hospitalization during the 120 days after the earliest observed methotrexate prescription

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Musculoskeletal Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      Resolution Health, Inc.
      Steward Organization POC Email
      [email protected]